BioNexus Gene Lab Corp (BGLC) — Gross Profit
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $1.09M | -15.8% |
| 2024 | $1.29M | -3.0% |
| 2023 | $1.33M | +5.6% |
| 2022 | $1.26M | -44.5% |
| 2021 | $2.27M | +31.8% |
| 2020 | $1.72M | +2977.3% |
| 2019 | $55.9K | +94.3% |
| 2018 | $28.8K | — |
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $1.09M | -15.8% |
| 2024 | $1.29M | -3.0% |
| 2023 | $1.33M | +5.6% |
| 2022 | $1.26M | -44.5% |
| 2021 | $2.27M | +31.8% |
| 2020 | $1.72M | +2977.3% |
| 2019 | $55.9K | +94.3% |
| 2018 | $28.8K | — |